Dr. J. Joseph Kim, CEO at Inovio Pharmaceuticals, discusses vaccine development for COVID-19. Kim points out that there's been "a lot of incremental successes" in phase one trials. He also talks about the importance of ensuring safety and efficacy.
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
Fler avsnitt av Bloomberg Businessweek
Visa alla avsnitt av Bloomberg BusinessweekBloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
